Nanjing Leads Biolabs Co., Ltd. reported no movements in either authorised or issued share capital for the month ended 31 March 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing Limited.

Authorised/registered share capital remained unchanged at RMB 198.89 million, comprising: • 153.28 million H-shares listed in Hong Kong with a nominal value of RMB 1 each. • 45.61 million unlisted domestic shares, also at RMB 1 par value.

Issued share capital mirrored the authorised structure and likewise showed no change during the month: • 153.28 million H-shares in issue and nil treasury shares. • 45.61 million unlisted shares in issue.

The company confirmed that as at 31 March 2026 the applicable minimum public-float threshold—25 % of the total issued H-shares—was satisfied.

No share options, warrants, convertible securities, or other agreements that could lead to equity dilution were outstanding or executed during the period, and no treasury-share transactions occurred.